The current standard treatment for type 1 Gaucher disease is enzyme replacement therapy using infusions of natural or recombinant forms of glucocerebrosidase, the lysosomal enzyme that is deficient in Gaucher disease. Enzyme replacement therapy is generally well tolerated and has not been linked to serum enzyme elevations or to instances of clinically apparent acute liver injury.